Literature DB >> 22508990

Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression.

Alexander Hoellein1, Steffi Graf, Florian Bassermann, Stephanie Schoeffmann, Ulrich Platz, Gabriele Hölzlwimmer, Monika Kröger, Christian Peschel, Robert Oostendorp, Leticia Quintanilla-Fend, Ulrich Keller.   

Abstract

Cks1 is an activator of the SCF(Skp2) ubiquitin ligase complex that targets the cell cycle inhibitor p27(Kip1) for degradation. The loss of Cks1 results in p27(Kip1) accumulation and decreased proliferation and inhibits tumorigenesis. We identify here a function of Cks1 in mammalian cell cycle regulation that is independent of p27(Kip1). Specifically, Cks1(-/-); p27(Kip1-/-) mouse embryonic fibroblasts retain defects in the G(1)-S phase transition that are coupled with decreased Cdk2-associated kinase activity and defects in proliferation that are associated with Cks1 loss. Furthermore, concomitant loss of Cks1 does not rescue the tumor suppressor function of p27(Kip1) that is manifest in various organs of p27(Kip1-/-) mice. In contrast, defects in mitotic entry and premature senescence manifest in Cks1(-/-) cells are p27(Kip1) dependent. Collectively, these findings establish p27(Kip1)-independent functions of Cks1 in regulating the G(1)-S transition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508990      PMCID: PMC3434501          DOI: 10.1128/MCB.06771-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity.

Authors:  A De Luca; T K MacLachlan; L Bagella; C Dean; C M Howard; P P Claudio; A Baldi; K Khalili; A Giordano
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

2.  Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.

Authors:  S Lacy; P Whyte
Journal:  Oncogene       Date:  1997-05-22       Impact factor: 9.867

3.  The Cdk-associated protein Cks1 functions both in G1 and G2 in Saccharomyces cerevisiae.

Authors:  Y Tang; S I Reed
Journal:  Genes Dev       Date:  1993-05       Impact factor: 11.361

4.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

5.  A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice.

Authors:  M L Fero; M Rivkin; M Tasch; P Porter; C E Carow; E Firpo; K Polyak; L H Tsai; V Broudy; R M Perlmutter; K Kaushansky; J M Roberts
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

6.  Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

Authors:  H Kiyokawa; R D Kineman; K O Manova-Todorova; V C Soares; E S Hoffman; M Ono; D Khanam; A C Hayday; L A Frohman; A Koff
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

7.  Distinct roles for cyclin-dependent kinases in cell cycle control.

Authors:  S van den Heuvel; E Harlow
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

8.  Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1.

Authors:  Y Bourne; M H Watson; M J Hickey; W Holmes; W Rocque; S I Reed; J A Tainer
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

9.  Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain.

Authors:  A S Arvai; Y Bourne; M J Hickey; J A Tainer
Journal:  J Mol Biol       Date:  1995-06-23       Impact factor: 5.469

10.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

Authors:  M Pagano; S W Tam; A M Theodoras; P Beer-Romero; G Del Sal; V Chau; P R Yew; G F Draetta; M Rolfe
Journal:  Science       Date:  1995-08-04       Impact factor: 47.728

View more
  5 in total

1.  Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors.

Authors:  V Tomiatti; R Istvánffy; E Pietschmann; S Kratzat; A Hoellein; L Quintanilla-Fend; N von Bubnoff; C Peschel; R A J Oostendorp; U Keller
Journal:  Oncogene       Date:  2014-11-24       Impact factor: 9.867

2.  SIRT1 regulates the phosphorylation and degradation of P27 by deacetylating CDK2 to promote T-cell acute lymphoblastic leukemia progression.

Authors:  Fangce Wang; Zheng Li; Jie Zhou; Guangming Wang; Wenjun Zhang; Jun Xu; Aibin Liang
Journal:  J Exp Clin Cancer Res       Date:  2021-08-18

3.  Cks1: Structure, Emerging Roles and Implications in Multiple Cancers.

Authors:  Vinayak Khattar; Jaideep V Thottassery
Journal:  J Cancer Ther       Date:  2013-10-01

4.  Rho-associated kinase (ROCK) function is essential for cell cycle progression, senescence and tumorigenesis.

Authors:  Sandra Kümper; Faraz K Mardakheh; Afshan McCarthy; Maggie Yeo; Gordon W Stamp; Angela Paul; Jonathan Worboys; Amine Sadok; Claus Jørgensen; Sabrina Guichard; Christopher J Marshall
Journal:  Elife       Date:  2016-01-14       Impact factor: 8.140

5.  The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability.

Authors:  William Grey; Adam Ivey; Thomas A Milne; Torsten Haferlach; David Grimwade; Frank Uhlmann; Edwige Voisset; Veronica Yu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-09-20       Impact factor: 4.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.